SCHEMBL3521880

SCHEMBL3521880

COC(=O)c1c(OC)c(Cl)cc2nccnc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
KDM4E B2RXH2 3/20 0.39
GAA P10253 2/20 0.39
HSD17B10 Q99714 2/20 0.38
TAS1R3 Q7RTX0 2/20 0.38
TAS1R1 Q7RTX1 2/20 0.38
MAPK8 P45983 1/20 0.37
MAPK9 P45984 1/20 0.37
MAPK10 P53779 1/20 0.37
TAS1R2 Q8TE23 1/20 0.36
MEN1 O00255 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
HPGD P15428 2/20 0.36
TPMT P51580 1/20 0.36
HTT P42858 2/20 0.35
TSHR P16473 2/20 0.35
ALOX15 P16050 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3521595 0.82 MAPT (0.37) ALDH1A1HSD17B10MAPK8MAPK9MAPK10
SCHEMBL3518477 0.82 MAPK8 (0.37) ALDH1A1KDM4EGAAMAPK8MAPK9
SCHEMBL3520012 0.80 MAPK8 (0.35) ALDH1A1KDM4EGAAMAPK8MAPK9
SCHEMBL3520015 0.78 MAPK8 (0.39) MAPK8MAPK9MAPK10HTTALOX15
SCHEMBL3530106 0.75 CFTR (0.43) MAPK8MAPK9MAPK10HTTALOX15
SCHEMBL19893383 0.74 HTT (0.44) ALDH1A1KDM4EGAAMEN1RAB9A
SCHEMBL3758964 0.71 MEN1 (0.54) KDM4EGAAMAPK8MAPK9MAPK10
SCHEMBL6904787 0.70 GAA (0.49) ALDH1A1KDM4EGAAHSD17B10TAS1R3
SCHEMBL17318733 0.69 POLB (0.46) ALDH1A1KDM4EGAAHSD17B10TAS1R3
SCHEMBL30892255 0.69 POLB (0.46) ALDH1A1KDM4EGAAHSD17B10TAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101983384-A Prolyl hydroxylase inhibitors SMITHKLINE BEECHAM CORP 2011-03-02 CN disclosed
US-20100305133-A1 Prolyl Hydroxylase Inhibitors SMITHKLINE BEECHAM CORPORATION 2010-12-02 US disclosed
EP-2227770-A2 PROLYL HYDROXYLASE INHIBITORS GlaxoSmithKline LLC (US) 2010-09-15 EP disclosed
WO-2009073497-A2 PROLYL HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305133-A1 Prolyl Hydroxylase Inhibitors HIF1AN, EGLN3, EGLN2 ALDH1A1 191/4885KDM4E 176/4885GAA 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.